Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Initially implemented to help monitor the CV safety of glucose-lowering drugs in patients with T2D, who either had established CVD or were at high risk of CVD, data that emerged from some of these trials started to show benefits
Expect steady progress over weeks to months with dose escalation and ongoing lifestyle support
It is believed to stimulate muscle development and improve overall recovery after exercise
Read our full UK legal analysis
If any unusual reaction appears after the first injection, the treatment should be stopped immediately
US$ 24.97
US$ 20.16
US$ 23.69
US$ 20.89
US$ 20.42
